Akums Drugs & Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹577.05Day's Price Range₹62652 Week's Low
52 Week's High
₹530.0552-Week Price Range₹1,175.9
| Returns % | |
| 1 Month Return | -11.34 % |
| 3 Month Return | -28.68 % |
| 1 Year Return | -25.16 % |
| Market Stats | |
| Previous Close | ₹597.90 |
| Open | ₹598.00 |
| Volume | 13.81L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹9,379.11Cr |
Akums Drugs & Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 30.99 |
| PEG Ratio | 1.03 |
| Market Cap | ₹9,379.11 Cr |
| P/B Ratio | 0 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 91.28 |
Akums Drugs & Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹9,379.11 Cr | -5.03% | 0.00 | ₹97 Cr | ₹4,178 Cr | |
| NA | ₹887.00 Cr | 264.92% | 0.91 | ₹55 Cr | ₹575 Cr | |
| NA | ₹2,407.31 Cr | 159.02% | 0.62 | ₹43 Cr | ₹381 Cr | |
| NA | ₹930.38 Cr | 681.88% | 0.65 | ₹23 Cr | ₹307 Cr | |
| NA | ₹519.70 Cr | 31.31% | 0.56 | ₹13 Cr | ₹154 Cr |
Akums Drugs & Pharmaceuticals Ltd Mutual Fund Holdings
About Akums Drugs & Pharmaceuticals Ltd
Share Price: ₹595.90 per share as on 24 Dec, 2024 04:01 PM
Market Capitalisation: ₹9,379.11Cr as of today
Revenue: ₹1,033.09Cr as on September 2024 (Q3 24)
Net Profit: ₹66.65Cr as on September 2024 (Q3 24)
Listing date: 06 Aug, 2024
| Organisation | Akums Drugs & Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Akums Drugs & Pharmaceuticals Ltd
Akums Drugs Secures Major European CDMO Agreement - 24 Dec, 2024
Akums Drugs has entered a ₹1,760 crore CDMO agreement with a leading global pharma company to supply oral liquid formulations in Europe, starting in 2027. The deal includes an upfront payment of ₹880 crore and aims to expand Akums' presence in regulated markets.Akums Partners with Caregen, Hits Upper Circuit Limit - 29 Nov, 2024
Akums Drugs & Pharmaceuticals has entered a strategic partnership with Caregen for specialty nutraceuticals and cosmeceuticals. Shares surged to the upper circuit limit following this announcement and a collaboration with Maxcure Nutravedics for the Ready-to-Drink market.Akums Secures Collaborations and Hits Circuit Limit - 26 Nov, 2024
Akums Drugs & Pharmaceuticals' subsidiary Maxcure Nutravedics has partnered with Jagdale Industries for RTD products. Additionally, Akums shares reached a 5% upper circuit limit after announcing an exclusive sales agreement with Caregen Co. Ltd.
Insights on Akums Drugs & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, AKUMS stock has moved up by 4.5%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 3.07% to 5.18% in Sep 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 5.32% to 7.34% in Sep 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 75.26% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 9.09% to 7.15% in Sep 2024 quarter
Akums Drugs & Pharmaceuticals Ltd Financials
Index Inclusions
Akums Drugs & Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 75.26% | 0.00 | |
| Foreign Institutions | 7.34% | 37.95 | |
| Mutual Funds | 5.18% | 68.40 | |
| Retail Investors | 7.15% | ||
| Others | 5.07% |
Akums Drugs & Pharmaceuticals Ltd Key Indicators
Akums Drugs & Pharmaceuticals Ltd Valuation
Akums Drugs & Pharmaceuticals Ltd in the last 5 years
Lowest (28.76x)
November 18, 2024
Today (30.99x)
December 24, 2024
Industry (56.56x)
December 24, 2024
Highest (65.57x)
August 19, 2024
Akums Drugs & Pharmaceuticals Ltd Earnings and Dividends
Akums Drugs & Pharmaceuticals Ltd Earnings Results
Akums Drugs & Pharmaceuticals Ltd’s net profit jumped 105% since last year same period to ₹65.21Cr in the Q2 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated 8.38% jump in its net profits since last 3-months.
Read More about Earnings Results
Akums Drugs & Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Akums Drugs & Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Akums Drugs & Pharmaceuticals Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Akums Drugs & Pharmaceuticals Ltd shares.
Akums Drugs & Pharmaceuticals Ltd (AKUMS) share price today is ₹595.9
Akums Drugs & Pharmaceuticals Ltd is listed on NSE
Akums Drugs & Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Akums Drugs & Pharmaceuticals Ltd is ₹626.
- Today’s lowest price of Akums Drugs & Pharmaceuticals Ltd is ₹577.05.
PE Ratio of Akums Drugs & Pharmaceuticals Ltd is 30.99
PE ratio = Akums Drugs & Pharmaceuticals Ltd Market price per share / Akums Drugs & Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Akums Drugs & Pharmaceuticals Ltd(AKUMS) is 13.81L.
Today’s market capitalisation of Akums Drugs & Pharmaceuticals Ltd(AKUMS) is ₹9379.11Cr.
| Akums Drugs & Pharmaceuticals Ltd(AKUMS | Price |
|---|---|
52 Week High | ₹1175.9 |
52 Week Low | ₹530.05 |
Akums Drugs & Pharmaceuticals Ltd(AKUMS) share price is ₹595.9. It is down -49.32% from its 52 Week High price of ₹1175.9
Akums Drugs & Pharmaceuticals Ltd(AKUMS) share price is ₹595.9. It is up 12.42% from its 52 Week Low price of ₹530.05
| Akums Drugs & Pharmaceuticals Ltd(AKUMS | Returns |
|---|---|
1 Day Returns | -2% |
1 Month Returns | -11.34% |
3 Month Returns | -28.68% |
1 Year Returns | -25.16% |